SCHEMBL3504318

SCHEMBL3504318

CNC(=O)Oc1ccc2c(NCCN3CCOCC3)noc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HSP90AA1 P07900 2/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HBB P68871 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ USP2 O75604 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CLK4 Q9HAZ1 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ BCR P11274 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505069 0.94 GAA (0.45) ACHEALDH1A1MEN1KMT2AHSD17B10
SCHEMBL3503323 0.92 HSP90AA1 (0.45) ACHEALDH1A1HSP90AA1HSP90AB1MAPK1
SCHEMBL3504561 0.87 ALDH1A1 (0.46) CSNK2A1ALDH1A1HSP90AA1HSP90AB1MEN1
SCHEMBL6959886 0.84 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AHSD17B10USP2
SCHEMBL6951018 0.84 HRH3 (0.45) ACHEALDH1A1MEN1KMT2AHSD17B10
SCHEMBL9085767 0.81 NR1I3 (0.46) ACHECSNK2A1ALDH1A1HSP90AA1HSP90AB1
SCHEMBL3505067 0.81 ACHE (0.40) ACHEALDH1A1HSD17B10LMNAGAA
SCHEMBL6956983 0.80 POLB (0.52) ACHEKMT2AMAPK1LMNAGAA
SCHEMBL3507456 0.79 EPHX2 (0.41) ACHEALDH1A1HSD17B10LMNAGAA
SCHEMBL3505581 0.79 HSP90AA1 (0.50) ACHECSNK2A1ALDH1A1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 — — US disclosed
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback